ID   PLCB_HUMAN              Reviewed;         278 AA.
AC   O15120; O00516; O15106; Q5VUD3; Q5VUD4; Q9BSV7; Q9BWR7;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=1-acyl-sn-glycerol-3-phosphate acyltransferase beta;
DE            EC=2.3.1.51;
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 2;
DE            Short=1-AGP acyltransferase 2;
DE            Short=1-AGPAT 2;
DE   AltName: Full=Lysophosphatidic acid acyltransferase beta;
DE            Short=LPAAT-beta;
DE   Flags: Precursor;
GN   Name=AGPAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=9242711; DOI=10.1074/jbc.272.32.20299;
RA   Eberhardt C., Gray P.W., Tjoelker L.W.;
RT   "Human lysophosphatidic acid acyltransferase. cDNA cloning,
RT   expression, and localization to chromosome 9q34.3.";
RL   J. Biol. Chem. 272:20299-20305(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9291118; DOI=10.1042/bj3260455;
RA   Stamps A.C., Elmore M.A., Hill M.E., Kelly K., Makda A.A.,
RA   Finnen M.J.;
RT   "A human cDNA sequence with homology to non-mammalian lysophosphatidic
RT   acid acyltransferases.";
RL   Biochem. J. 326:455-461(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9212163;
RA   West J., Tompkins C.K., Balantac N., Nudelman E., Meengs B., White T.,
RA   Bursten S., Coleman J., Kumar A., Singer J.W., Leung D.W.;
RT   "Cloning and expression of two human lysophosphatidic acid
RT   acyltransferase cDNAs that enhance cytokine-induced signaling
RT   responses in cells.";
RL   DNA Cell Biol. 16:691-701(1997).
RN   [4]
RP   SEQUENCE REVISION TO 51.
RA   Leung D.W., Tompkin C.K., West J.;
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   REVIEW.
RX   PubMed=15028826; DOI=10.1056/NEJMra025261;
RA   Garg A.;
RT   "Acquired and inherited lipodystrophies.";
RL   N. Engl. J. Med. 350:1220-1234(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND CHARACTERIZATION OF VARIANTS CGL1
RP   ARG-136; PHE-140 DEL; PRO-228 AND VAL-239.
RX   PubMed=15629135; DOI=10.1016/j.bbrc.2004.12.024;
RA   Haque W., Garg A., Agarwal A.K.;
RT   "Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-
RT   O-acyltransferase 2 mutants associated with congenital generalized
RT   lipodystrophy.";
RL   Biochem. Biophys. Res. Commun. 327:446-453(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21873652; DOI=10.1074/jbc.M111.250449;
RA   Agarwal A.K., Sukumaran S., Cortes V.A., Tunison K., Mizrachi D.,
RA   Sankella S., Gerard R.D., Horton J.D., Garg A.;
RT   "Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2:
RT   biochemical characterization and inability to rescue hepatic steatosis
RT   in Agpat2(-/-) gene lipodystrophic mice.";
RL   J. Biol. Chem. 286:37676-37691(2011).
RN   [12]
RP   VARIANTS CGL1 ARG-136; PHE-140 DEL; PRO-228 AND VAL-239.
RX   PubMed=11967537; DOI=10.1038/ng880;
RA   Agarwal A.K., Arioglu E., de Almeida S., Akkoc N., Taylor S.I.,
RA   Bowcock A.M., Barnes R.I., Garg A.;
RT   "AGPAT2 is mutated in congenital generalized lipodystrophy linked to
RT   chromosome 9q34.";
RL   Nat. Genet. 31:21-23(2002).
CC   -!- FUNCTION: Converts lysophosphatidic acid (LPA) into phosphatidic
CC       acid by incorporating an acyl moiety at the sn-2 position of the
CC       glycerol backbone. {ECO:0000269|PubMed:15629135,
CC       ECO:0000269|PubMed:21873652, ECO:0000269|PubMed:9242711}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate =
CC       CoA + 1,2-diacyl-sn-glycerol 3-phosphate.
CC       {ECO:0000269|PubMed:15629135, ECO:0000269|PubMed:21873652,
CC       ECO:0000269|PubMed:9242711}.
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis;
CC       CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21873652}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:21873652}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15120-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15120-2; Sequence=VSP_005071;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in adipose tissue,
CC       pancreas and liver. {ECO:0000269|PubMed:21873652}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity
CC       and may constitute the binding site for the phosphate moiety of
CC       the glycerol-3-phosphate. {ECO:0000250}.
CC   -!- DISEASE: Congenital generalized lipodystrophy 1 (CGL1)
CC       [MIM:608594]: An autosomal recessive disorder characterized by a
CC       near complete absence of adipose tissue, extreme insulin
CC       resistance, hypertriglyceridemia, hepatic steatosis and early
CC       onset of diabetes. {ECO:0000269|PubMed:11967537,
CC       ECO:0000269|PubMed:15629135}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000237; AAC51649.1; -; mRNA.
DR   EMBL; AF011374; AAB64299.1; -; mRNA.
DR   EMBL; U56418; AAB58776.2; -; mRNA.
DR   EMBL; AL590226; CAH71722.1; -; Genomic_DNA.
DR   EMBL; AL590226; CAH71723.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88249.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88251.1; -; Genomic_DNA.
DR   EMBL; BC000026; AAH00026.1; -; mRNA.
DR   EMBL; BC004529; AAH04529.1; -; mRNA.
DR   CCDS; CCDS35181.1; -. [O15120-2]
DR   CCDS; CCDS7003.1; -. [O15120-1]
DR   RefSeq; NP_001012745.1; NM_001012727.1. [O15120-2]
DR   RefSeq; NP_006403.2; NM_006412.3. [O15120-1]
DR   UniGene; Hs.320151; -.
DR   ProteinModelPortal; O15120; -.
DR   BioGrid; 115806; 11.
DR   IntAct; O15120; 6.
DR   STRING; 9606.ENSP00000360761; -.
DR   BindingDB; O15120; -.
DR   ChEMBL; CHEMBL4772; -.
DR   SwissLipids; SLP:000000096; -.
DR   iPTMnet; O15120; -.
DR   PhosphoSitePlus; O15120; -.
DR   BioMuta; AGPAT2; -.
DR   EPD; O15120; -.
DR   MaxQB; O15120; -.
DR   PaxDb; O15120; -.
DR   PeptideAtlas; O15120; -.
DR   PRIDE; O15120; -.
DR   DNASU; 10555; -.
DR   Ensembl; ENST00000371694; ENSP00000360759; ENSG00000169692. [O15120-2]
DR   Ensembl; ENST00000371696; ENSP00000360761; ENSG00000169692. [O15120-1]
DR   Ensembl; ENST00000538402; ENSP00000438919; ENSG00000169692. [O15120-1]
DR   GeneID; 10555; -.
DR   KEGG; hsa:10555; -.
DR   UCSC; uc004cii.2; human. [O15120-1]
DR   CTD; 10555; -.
DR   DisGeNET; 10555; -.
DR   GeneCards; AGPAT2; -.
DR   GeneReviews; AGPAT2; -.
DR   HGNC; HGNC:325; AGPAT2.
DR   HPA; HPA019544; -.
DR   MalaCards; AGPAT2; -.
DR   MIM; 603100; gene.
DR   MIM; 608594; phenotype.
DR   neXtProt; NX_O15120; -.
DR   OpenTargets; ENSG00000169692; -.
DR   Orphanet; 528; Berardinelli-Seip congenital lipodystrophy.
DR   PharmGKB; PA24622; -.
DR   eggNOG; KOG2848; Eukaryota.
DR   eggNOG; COG0204; LUCA.
DR   GeneTree; ENSGT00390000008726; -.
DR   HOVERGEN; HBG000676; -.
DR   InParanoid; O15120; -.
DR   KO; K13509; -.
DR   OMA; MSIISWF; -.
DR   OrthoDB; EOG091G0ICC; -.
DR   PhylomeDB; O15120; -.
DR   TreeFam; TF314867; -.
DR   BioCyc; MetaCyc:HS09990-MONOMER; -.
DR   BRENDA; 2.3.1.51; 2681.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   UniPathway; UPA00557; UER00613.
DR   GeneWiki; AGPAT2; -.
DR   GenomeRNAi; 10555; -.
DR   PRO; PR:O15120; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000169692; -.
DR   CleanEx; HS_AGPAT2; -.
DR   ExpressionAtlas; O15120; baseline and differential.
DR   Genevisible; O15120; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008544; P:epidermis development; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; IGI:BHF-UCL.
DR   GO; GO:0006644; P:phospholipid metabolic process; NAS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IMP:BHF-UCL.
DR   GO; GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IC:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR004552; AGP_acyltrans.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   SMART; SM00563; PlsC; 1.
DR   TIGRFAMs; TIGR00530; AGP_acyltrn; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Complete proteome;
KW   Congenital generalized lipodystrophy; Diabetes mellitus;
KW   Disease mutation; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome; Signal; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    278       1-acyl-sn-glycerol-3-phosphate
FT                                acyltransferase beta.
FT                                /FTId=PRO_0000208192.
FT   TRANSMEM     30     50       Helical. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   MOTIF        98    103       HXXXXD motif.
FT   MOTIF       172    175       EGTR motif.
FT   VAR_SEQ     165    196       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_005071.
FT   VARIANT     136    136       G -> R (in CGL1; reduced 1-acyl-sn-
FT                                glycerol-3-phosphate acyltransferase
FT                                activity; dbSNP:rs797045222).
FT                                {ECO:0000269|PubMed:11967537,
FT                                ECO:0000269|PubMed:15629135}.
FT                                /FTId=VAR_017328.
FT   VARIANT     140    140       Missing (in CGL1; reduced 1-acyl-sn-
FT                                glycerol-3-phosphate acyltransferase
FT                                activity). {ECO:0000269|PubMed:11967537,
FT                                ECO:0000269|PubMed:15629135}.
FT                                /FTId=VAR_017326.
FT   VARIANT     228    228       L -> P (in CGL1; reduced 1-acyl-sn-
FT                                glycerol-3-phosphate acyltransferase
FT                                activity; dbSNP:rs104894100).
FT                                {ECO:0000269|PubMed:11967537,
FT                                ECO:0000269|PubMed:15629135}.
FT                                /FTId=VAR_017327.
FT   VARIANT     239    239       A -> V (in CGL1; 90% of wild-type 1-acyl-
FT                                sn-glycerol-3-phosphate acyltransferase
FT                                activity; dbSNP:rs145975461).
FT                                {ECO:0000269|PubMed:11967537,
FT                                ECO:0000269|PubMed:15629135}.
FT                                /FTId=VAR_017325.
FT   CONFLICT    126    126       L -> V (in Ref. 2; AAB64299).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       V -> F (in Ref. 7; AAH00026).
FT                                {ECO:0000305}.
SQ   SEQUENCE   278 AA;  30914 MW;  1E58F537F703BE9F CRC64;
     MELWPCLAAA LLLLLLLVQL SRAAEFYAKV ALYCALCFTV SAVASLVCLL RHGGRTVENM
     SIIGWFVRSF KYFYGLRFEV RDPRRLQEAR PCVIVSNHQS ILDMMGLMEV LPERCVQIAK
     RELLFLGPVG LIMYLGGVFF INRQRSSTAM TVMADLGERM VRENLKVWIY PEGTRNDNGD
     LLPFKKGAFY LAVQAQVPIV PVVYSSFSSF YNTKKKFFTS GTVTVQVLEA IPTSGLTAAD
     VPALVDTCHR AMRTTFLHIS KTPQENGATA GSGVQPAQ
//
